1. Home
  2. CURR vs ICCM Comparison

CURR vs ICCM Comparison

Compare CURR & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURR
  • ICCM
  • Stock Information
  • Founded
  • CURR 2013
  • ICCM 2006
  • Country
  • CURR Singapore
  • ICCM Israel
  • Employees
  • CURR N/A
  • ICCM N/A
  • Industry
  • CURR Business Services
  • ICCM
  • Sector
  • CURR Consumer Discretionary
  • ICCM
  • Exchange
  • CURR Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • CURR 74.0M
  • ICCM 59.5M
  • IPO Year
  • CURR N/A
  • ICCM N/A
  • Fundamental
  • Price
  • CURR $0.43
  • ICCM $0.95
  • Analyst Decision
  • CURR Strong Buy
  • ICCM Strong Buy
  • Analyst Count
  • CURR 1
  • ICCM 1
  • Target Price
  • CURR $3.50
  • ICCM $2.50
  • AVG Volume (30 Days)
  • CURR 2.5M
  • ICCM 221.0K
  • Earning Date
  • CURR 08-11-2025
  • ICCM 08-19-2025
  • Dividend Yield
  • CURR N/A
  • ICCM N/A
  • EPS Growth
  • CURR N/A
  • ICCM N/A
  • EPS
  • CURR N/A
  • ICCM N/A
  • Revenue
  • CURR $43,386,858.00
  • ICCM $3,273,000.00
  • Revenue This Year
  • CURR N/A
  • ICCM $83.41
  • Revenue Next Year
  • CURR $21.53
  • ICCM $185.02
  • P/E Ratio
  • CURR N/A
  • ICCM N/A
  • Revenue Growth
  • CURR N/A
  • ICCM 0.34
  • 52 Week Low
  • CURR $0.33
  • ICCM $0.48
  • 52 Week High
  • CURR $7.08
  • ICCM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • CURR N/A
  • ICCM 37.48
  • Support Level
  • CURR N/A
  • ICCM $0.98
  • Resistance Level
  • CURR N/A
  • ICCM $1.00
  • Average True Range (ATR)
  • CURR 0.00
  • ICCM 0.04
  • MACD
  • CURR 0.00
  • ICCM -0.00
  • Stochastic Oscillator
  • CURR 0.00
  • ICCM 6.46

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: